Børge Nordestgaard: Lp(a) Remains a Risk Factor Across the Lifespan
Børge Nordestgaard, Professor and Chief Physician at Herlev og Gentofte Hospital, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Circulation, adding:
”In a contemporary primary prevention cohort (Copenhagen General Populatuion Study), the relative risk increase of ASCVD with higher Lp(a) levels was similar for individuals aged older (aged 70–100 years) and younger (aged 20-69 years) individuals, with the highest absolute risk in this older age group.
Written by Janeni Jeevanathan, Peter E. Thomas, Pia R. Kamstrup, and Børge Nordestgaard, and published in Circulation with simultaneous presentation at the 2026 ESC Congress in Munich yesterday.”
Title: Lipoprotein(a) and Atherosclerotic Cardiovascular Disease Among Adults Aged 20 to 100 Years
Authors: Janeni Jeevanathan, Peter E. Thomas, Pia R. Kamstrup, Børge G. Nordestgaard
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 4, 2026, 18:22Tareq Abadl: The Clinical Meaning of C3 and C4
-
Sep 4, 2026, 18:16How Mutant p53 Hijacks VWF Expression in Tumor Cells – JTH
-
Sep 4, 2026, 18:08Simon Kraler: Can the Adrenomedullin System Predict Cardiogenic Shock Before It Happens?
-
Sep 4, 2026, 17:56Maxime Dely: Why Every Blood Donation Matters
-
Sep 4, 2026, 17:28Shinya Goto: When Cardiovascular Risk Gets Lower, RCTs Get Harder
-
Sep 4, 2026, 16:55New Orleans Is Calling ASH26 Is Near
-
Sep 4, 2026, 16:48ESC Congress 2026 – My Top 20 Lipidology Highlights Shaping the Future of Cardiovascular Prevention – Pablo Corral
-
Sep 4, 2026, 16:38Felice Gragnano։ Turning Cardiovascular Risk Into Action
-
Sep 4, 2026, 16:30Lisa Littner: The Hidden Burden of Prior Authorization in Bleeding Disorder Care